Global Glycated Haemoglobin Testing Market Size To Exceed USD 601.20 Million By 2035 | CAGR of 8.74%
Category: HealthcareGlobal Glycated Haemoglobin Testing Market Size To Exceed USD 601.20 Million By 2035
According to a research report published by Spherical Insights & Consulting, the Global Glycated Haemoglobin Testing Market Size is Expected to Grow from USD 239.12 Million in 2024 to USD 601.20 Million by 2035, at a CAGR of 8.74% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 260 pages with 110 Market data tables and figures & charts from the report on the "Global Glycated Haemoglobin Testing Market Size, Share, and COVID-19 Impact Analysis, Product Type (Laboratory-Based Analyzers, and Point of Care (POC) Analyzers), By End User (Hospitals, Physical Examination Institution, Research Institutions, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/glycated-haemoglobin-testing-market
The development, manufacturing, and distribution of diagnostic tools and services for measuring blood levels of glycated hemoglobin (HbA1c) is referred to as the "glycated hemoglobin testing market." An important tool for diagnosing, tracking, and treating diabetes, this test provides the average blood glucose level for the last two to three months. The market includes laboratory-based analyzers, point-of-care testing equipment, and associated reagents that enable healthcare providers to effectively treat diabetes. The growing number of diabetics and growing awareness of POC HbA1c testing in developing countries are expected to fuel glycated hemoglobin testing market expansion. Glycated hemoglobin testing and other routine blood sugar monitoring tests are necessary due to the rising number of obese individuals, which also raises the risk of diabetes. The market for glycated hemoglobin testing is being driven primarily by advancements in point-of-care technology, rising diabetes prevalence, growing demand for early diagnosis, and greater awareness of long-term glucose monitoring. However, high testing prices, restricted availability in remote regions, and a lack of knowledge about diabetes monitoring are the main factors restricting the glycated hemoglobin testing market.
The laboratory-based analyzers segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product type, the glycated hemoglobin testing market is divided into laboratory-based analyzers, and point of care (POC) analyzers. Among these, the laboratory-based analyzers segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Laboratory-based analyzers' automation and high-throughput capabilities enable clinical labs to process hundreds of samples in a matter of hours with reliable findings, increasing productivity.
The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the end user, the glycated hemoglobin testing market is divided into hospitals, physical examination institution, research institutions, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Hospitals sector is ascribed to the extensive range of medical services these establishments offer, such as sophisticated diagnostic tools and integrated care models that support efficient diabetes treatment.
North America is expected to hold the majority share of the global glycated hemoglobin testing market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global glycated hemoglobin testing market during the forecast period. The primary findings of the study indicate that glycated hemoglobin testing services are most in demand in the US and Canada. North America's dominant position in the worldwide industry is further supported by supportive government programs and greater awareness of diabetes control.
Asia Pacific is anticipated to grow at the fastest pace in the global glycated hemoglobin testing market during the forecast period. The region's rapidly expanding market is also being fueled by advancements in healthcare infrastructure and the implementation of point-of-care testing.
Major vendors in the global glycated hemoglobin testing market are Abbott Laboratories, Beckman Coulter, Inc., ARKRAY, Inc., Tosoh Corporation, Roche Diagnostics, Bayer AG, Bio-Rad Laboratories, Inc., Alere Inc., Siemens Healthineers, Randox Laboratories Ltd., F. Hoffmann-La Roche Ltd., A.Menarini Diagnostics Ltd., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In January 2024, to improve the precision of diabetes diagnosis, Roche Diagnostics announced a new HbA1c testing tool.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the glycated hemoglobin testing market based on the below-mentioned segments:
Global Glycated Haemoglobin Testing Market, By Product Type
- Laboratory-based analyzers
- Point of Care (POC) analyzers
Global Glycated Haemoglobin Testing Market, By End User
- Hospitals
- Physical Examination Institution
- Research Institutions
- Others
Global Glycated Haemoglobin Testing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?